The coronavirus disease 2019 (COVID-19) pandemic continues to rapidly evolve. Given the origins of COVID-19 in China, there were initial concerns regarding medication shortages due to the reliance of the US on overseas manufacturing of active pharmaceutical ingredients. Although no major disruptions in pharmaceutical access have occurred this far. The future of the pandemic and […]